Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Net Income towards Common Stockholders (2016 - 2025)

Surgery Partners' Net Income towards Common Stockholders history spans 12 years, with the latest figure at $29.0 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 162.23% year-over-year to $29.0 million; the TTM value through Dec 2025 reached $98.9 million, up 691.2%, while the annual FY2025 figure was $98.9 million, 691.2% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $29.0 million at Surgery Partners, up from $25.3 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $57.7 million in Q2 2023 and bottomed at -$46.6 million in Q4 2024.
  • The 5-year median for Net Income towards Common Stockholders is $3.8 million (2023), against an average of $5.5 million.
  • The largest annual shift saw Net Income towards Common Stockholders plummeted 23300.0% in 2022 before it surged 1925.0% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$100000.0 in 2021, then tumbled by 23300.0% to -$23.4 million in 2022, then skyrocketed by 299.57% to $46.7 million in 2023, then tumbled by 199.79% to -$46.6 million in 2024, then soared by 162.23% to $29.0 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Net Income towards Common Stockholders are $29.0 million (Q4 2025), $25.3 million (Q3 2025), and $44.9 million (Q2 2025).